Jiangsu Bioperfectus Technologies Co., Ltd.

(SSE:688399)

BioPerfectus, a public listed company on Shanghai Stock Exchange (SSE:688399), has been one of the leading molecular diagnostic solution providers specialized in infectious diseases ever since 2010. With headquarters located in Jiangsu, subsidiaries in Shanghai, Beijing, Xi’an, Taizhou, Hainan, and Yinchuan. Bioperfectus is pioneering in molecular diagnostics market with our products ranging from real time PCR kits, nucleic acid extraction systems, rapid tests and automation laboratory devices. Young and passionate, Bioperfectus people are working steadily and firmly to achieve our dream of creating a healthier future for our next generations.

62,000+㎡

An industrial park of over 62,000㎡ integrating fully self-innovative R&D, production, warehousing, logistics, sales, marketing and customer service divisions catering for various business scenarios

800+

Over 800 Bioperfectus people’s permission gathering the perseverance and determination to fight against the global pandemic

5,000,000+

Production capacity ramping up to more than 5 million tests/day ensuring the quick sufficient response to infectious diseases

global presence

90 Countries within a year

Bioperfectus Products & Service have been distributed to over 80+ countries around the globe within only one year since the international business established.

10000 Machinery spots

Bioperfectus Nucleic Acid Extraction Solutions
were launched in over 10,000 laboratories
globally with a well-trained and quick-response
customer service team.

Product Center

News Center

06-282022

Bioperfectus Monkeypox Virus PCR Kit to Support Testing Across Africa

06-282022

June 28, 2022, Shanghai, China Jiangsu Bioperfectus Technologies Co., Ltd. (hereinafter referred to as Bioperfectus) Deputy General Manager Mr. TUNC MERT SAYIN addressed the opening ceremony of the Training Workshop on Monkeypox Diagnosis Using Real Time PCR Technique held by Africa Centers for Disease Control and Prevention (*hereinafter refer to as Africa CDC), African Union in collaboration with Nigeria Centre for Disease Control (Nigeria CDC) and African Society for Laboratory Medicine (AS...

06-222022

Next pandemic? Concerns growing as monkeypox virus cases surge

06-222022

The monkeypox virus, shown here in a colored electron micrograph, typically spreads by skin-to-skin contact or respiratory droplets. Sexual transmission may play a role in the new outbreak. CDC/CYNTHIA S. GOLDSMITH/SCIENCE SOURCE On 17 June, the WHO released its latest update on the Monkeypox outbreak situation. The sharp growth of confirmed cases during the last two months indicates increasing uncertainty of the endemic progress. Between 1 January and 15 June 2022, a cumulative total of 21...

06-172022

Bioperfectus Real-Time PCR Systems Included in FDA-listed for IVD Testing

06-172022

April 17, ShanghaiToday, we Bioperfectus are proud to announce that STC-96A and STC-96A PLUS Real-Time PCR Systems have been listed with the U.S. Food and Drug Administration (FDA) for IVD testing. With FDA registration, Bioperfectus Real-Time PCR Systems obtained access to PCR laboratories in the US. With stable performance and user-friendly design, STC-96A and STC-96A Plus will be great helpers for molecular laboratories to identify the virus and bacterial. Throughout the COVID-19 pand...

Learn More

Service Network

Support is only one step away

A good after-sales service is essential for efficiency of workload in PCR laboratory. Bioperfectus delivers most perfect service via our authorized distributors and global service center. With well-experienced service staff, sufficient spare-part inventory and fast global logistics, Bioperfectus aims to provide with the satisfactory solutions to our end users.We offer 24/7 after-sales service, prompt response and periodical training programs.

CONTACT US NOW